President and CEO of MAP PHARMACEUTICALS, INC. (MAPP, Financial) Timothy S Nelson sells 20,000 shares of MAPP on 01/11/2010 at an average price of $12.17 a share.
Map Pharmaceuticals, Inc. has a market cap of $304.2 million; its shares were traded at around $12.4 .
MAPP is in the portfolios of George Soros of Soros Fund Management LLC.
Map Pharmaceuticals, Inc. has a market cap of $304.2 million; its shares were traded at around $12.4 .
MAPP is in the portfolios of George Soros of Soros Fund Management LLC.
CFO Recent Trades:
- Sell:: CFO Christopher Y Chai sold 10,000 shares of MAPP stock on 11/02/2009 at the average price of 8.07, the price of the stock has increased by 53.66% since.
- Sell:: CFO Christopher Y Chai sold 10,000 shares of MAPP stock on 10/01/2009 at the average price of 10.26, the price of the stock has increased by 20.86% since.
Directors and Officers Recent Trades:
- Sell:: SVP, Cor & Business Dev Anastasios Gianakakos sold 4,500 shares of MAPP stock on 01/04/2010 at the average price of 9.92, the price of the stock has increased by 25% since.
- Sell:: Chief Scientific Officer Thomas A Armer sold 10,000 shares of MAPP stock on 12/14/2009 at the average price of 9.54, the price of the stock has increased by 29.98% since.
- Sell:: SVP, Cor & Business Dev Anastasios Gianakakos sold 4,500 shares of MAPP stock on 12/01/2009 at the average price of 9.11, the price of the stock has increased by 36.11% since.
- Sell:: Director Geraldine Henwood sold 16,250 shares of MAPP stock on 11/18/2009 at the average price of 8.77, the price of the stock has increased by 41.39% since.
- Sell:: SVP, Cor & Business Dev Anastasios Gianakakos sold 4,500 shares of MAPP stock on 11/02/2009 at the average price of 8.06, the price of the stock has increased by 53.85% since.
